Newsfeeds - Spark Newswire

1 minute read

Earnings

Recap: Theravance Biopharma Q2 Earnings

Today, 7:48 AM

Shares of Theravance Biopharma (NASDAQ:TBPH) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 20.00% year over year to ($0.80), which beat the estimate of ($1.01).

TBPH

1 minute read

Theravance Biopharma Q2 EPS $(0.80) Beats $(1.01) Estimate, Sales $12.91M Miss $15.41M Estimate

By Benzinga Newsdesk

Today, 7:48 AM

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.01) by 20.79 percent. This is a 20 percent increase over losses of $(1.00) per share from

TBPH

6 minute read

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly’s Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business

By Shanthi Rexaline

Today, 7:48 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2)

ABSI

21 minute read

Earnings Scheduled For August 3, 2021

By Benzinga Insights

Today, 7:48 AM

Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to report earnings for its second quarter.

AAIC